Introduction. Non-alcoholic fatty liver disease (NAFLD) is recognized worldwide as the most prevalent chronic liver disease with a high frequency among patients with type 2 diabetes (T2DM). This study aimed assessing the frequency of nonalcoholic fatty liver disease and advanced liver fibrosis in patients with type 2 diabetes. Material and methods. The cross-sectional study included 300 patients with T2DM (174 women and 126 men, with an average age of 58,94 ± 8,55 years), hospitalized between January and December 2022, in IMSP SCR "Timofei Moșneaga", Chisinau, Republic of Moldova. For evaluation were used the FLI calculator and the NAFLD Fibrosis Score. Results. Among the 300 patients included in the study, NAFLD is present in 75,67%. Analysis of the frequency of NAFLD according to gender showed no statistically significant differences between women and men. Analysis of the distribution of NAFLD according to BMI indicated that 76,2% of patients are obese. Using the NAFLD Fibrosis Score in patients with T2DM and NAFLD, it was found that advanced liver fibrosis (AdLF) was present in 18,50% patients (F3-F4), in 17,18% AdLF was excluded (F0- F2), and 64,32% patients presented an indeterminate score for AdLF. Conclusion. NAFLD is present in most patients with type 2 diabetes and especially in those with obesity. Most patients with NAFLD have an indeterminate advanced liver fibrosis score.